My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 73

    1.

    The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

    Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL.

    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.11. [Epub ahead of print]

    PMID:
    22286770
    [PubMed - as supplied by publisher]

    Related citations

    2.

    The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.

    Ursini-Siegel J, Hardy WR, Zheng Y, Ling C, Zuo D, Zhang C, Podmore L, Pawson T, Muller WJ.

    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.4. [Epub ahead of print]

    PMID:
    22286768
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.

    Maruani DM, Spiegel TN, Harris EN, Shachter AS, Unger HA, Herrero-González S, Holz MK.

    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.657. [Epub ahead of print]

    PMID:
    22286763
    [PubMed - as supplied by publisher]

    Related citations

    4.

    The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.

    Belguise K, Milord S, Galtier F, Moquet-Torcy G, Piechaczyk M, Chalbos D.

    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.659. [Epub ahead of print]

    PMID:
    22286759
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.

    Samanta S, Sharma VM, Khan A, Mercurio AM.

    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.620. [Epub ahead of print]

    PMID:
    22266872
    [PubMed - as supplied by publisher]

    Related citations

    6.

    RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

    Thaler S, Schmidt M, Schad A, Sleeman JP.

    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.658. [Epub ahead of print]

    PMID:
    22266866
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.

    Luker KE, Lewin SA, Mihalko LA, Schmidt BT, Winkler JS, Coggins NL, Thomas DG, Luker GD.

    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.633. [Epub ahead of print]

    PMID:
    22266857
    [PubMed - as supplied by publisher]

    Related citations

    8.

    Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.

    Castoria G, Giovannelli P, Lombardi M, De Rosa C, Giraldi T, de Falco A, Barone MV, Abbondanza C, Migliaccio A, Auricchio F.

    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.642. [Epub ahead of print]

    PMID:
    22266855
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression.

    Nairismägi ML, Vislovukh A, Meng Q, Kratassiouk G, Beldiman C, Petretich M, Groisman R, Füchtbauer EM, Harel-Bellan A, Groisman I.

    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.650. [Epub ahead of print]

    PMID:
    22266852
    [PubMed - as supplied by publisher]

    Related citations

    10.

    CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.

    Niemelä M, Kauko O, Sihto H, Mpindi JP, Nicorici D, Pernilä P, Kallioniemi OP, Joensuu H, Hautaniemi S, Westermarck J.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.599. [Epub ahead of print]

    PMID:
    22249265
    [PubMed - as supplied by publisher]

    Related citations

    11.

    Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.

    Cutrupi S, Reineri S, Panetto A, Grosso E, Caizzi L, Ricci L, Friard O, Agati S, Scatolini M, Chiorino G, Lykkesfeldt AE, De Bortoli M.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.627. [Epub ahead of print]

    PMID:
    22249258
    [PubMed - as supplied by publisher]

    Related citations

    12.

    FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.

    Wang J, Ray PS, Sim MS, Zhou XZ, Lu KP, Lee AV, Lin X, Bagaria SP, Giuliano AE, Cui X.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.635. [Epub ahead of print]

    PMID:
    22249250
    [PubMed - as supplied by publisher]

    Related citations

    13.

    Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.

    Wee EJ, Peters K, Nair SS, Hulf T, Stein S, Wagner S, Bailey P, Lee SY, Qu WJ, Brewster B, French JD, Dobrovic A, Francis GD, Clark SJ, Brown MA.

    Oncogene. 2012 Jan 9. doi: 10.1038/onc.2011.584. [Epub ahead of print]

    PMID:
    22231446
    [PubMed - as supplied by publisher]

    Related citations

    14.

    Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.

    Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G, Nassa G, Tarallo R, Cantarella C, Rizzo F, Di Benedetto A, Mottolese M, Benes V, Ambrosino C, Nola E, Weisz A.

    Oncogene. 2012 Jan 9. doi: 10.1038/onc.2011.583. [Epub ahead of print]

    PMID:
    22231442
    [PubMed - as supplied by publisher]

    Related citations

    15.

    A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.

    Anastas JN, Biechele TL, Robitaille M, Muster J, Allison KH, Angers S, Moon RT.

    Oncogene. 2011 Dec 19. doi: 10.1038/onc.2011.528. [Epub ahead of print]

    PMID:
    22179838
    [PubMed - as supplied by publisher]

    Related citations

    16.

    MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

    Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T, Schneeweiss A, Sahin O, Wiemann S, Tschulena U.

    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.571. [Epub ahead of print]

    PMID:
    22158050
    [PubMed - as supplied by publisher]

    Related citations

    17.

    Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.

    Khanal P, Yun HJ, Lim SC, Ahn SG, Yoon HE, Kang KW, Hong R, Choi HS.

    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.548. [Epub ahead of print]

    PMID:
    22158035
    [PubMed - as supplied by publisher]

    Related citations

    18.

    Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

    Pradeep CR, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.547. [Epub ahead of print]

    PMID:
    22139081
    [PubMed - as supplied by publisher]

    Related citations

    19.

    The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.

    Brennan DJ, O'Connor DP, Laursen H, McGee SF, McCarthy S, Zagozdzon R, Rexhepaj E, Culhane AC, Martin FM, Duffy MJ, Landberg G, Ryden L, Hewitt SM, Kuhar MJ, Bernards R, Millikan RC, Crown JP, Jirström K, Gallagher WM.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.519. [Epub ahead of print]

    PMID:
    22139072
    [PubMed - as supplied by publisher]

    Related citations

    20.

    A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.

    Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noël A, Foidart JM, Birembaut P, Polette M, Gilles C.

    Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.540. [Epub ahead of print]

    PMID:
    22120722
    [PubMed - as supplied by publisher]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk